Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-year follow-up of early extra MMR immunization
NL-OMON48447Active, not recruiting
- Sponsor
- National Institute for Public Health and the Environment
- Start
- Oct 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of measles, mumps, and rubella vaccine in measles, mumps and rubella (2 cohorts), sponsored by National Institute for Public Health and the Environment. Primary endpoint: Measles-specific serum neutralizing antibodies. Started Oct 2019; status: active, not recruiting.
02
Drugs
measles, mumps, and rubella vaccine
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NL-OMON48447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48447.